ReviewBioactive materials2026
Deep eutectic solvent-induced nanostructuring of cellulose gels: Review of mechanisms, properties, and applications.
Review in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cellulose Ionogels: Unraveling Structure-Property Relationships Through Multiscale In-Situ Characterization and Theoretical Modeling.Gels (Basel, Switzerland) · 2026Review
- Sustainable Carboxymethyl Cellulose-Based Foams via Deep Eutectic Solvent Processing for pH-Responsive Drug Delivery.Journal of functional biomaterials · 2026Article
- Acid-Based Deep Eutectic Solvents for Structural Modification of Sulphite Pulp Cellulose: A Potential Route Toward Advanced Materials.Polymers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellulose, the most abundant natural polymer on Earth, combines renewability, biocompatibility, and rich surface chemistry in ways that make it exceptionally suited for next-generation functional gel materials, yet its extensive inter- and intramolecular hydrogen bonding network and semicrystalline architecture create persistent challenges in processing, dissolution, and integration into high-performance systems requiring precise mechanical and ionic properties. Deep eutectic solvents (DESs) offer a compelling solution to these limitations: their tunable physicochemical characteristics allow them to function as affordable, customizable media capable of disrupting cellulose's recalcitrant structure while simultaneously contributing functional properties to the resulting materials. The combination of DESs with supporting polymer networks yields eutectogels, a class of materials distinguished by negligible volatility, robust mechanical strength, high ionic conductivity, and remarkable thermal and electrochemical stability, that have attracted growing interest for applications in biomedicine, solid-state electrolytes, sensors, soft robotics, and advanced functional systems. This review systematically examines recent progress in cellulose-based eutectogels, with particular emphasis on molecular-level design strategies such as dynamic covalent and noncovalent bonding, hierarchical assembly, and switchable supramolecular architectures that collectively enhance mechanical toughness, ionic transport, and autonomous self-healing. These approaches are critically evaluated in the context of responsive sensors for human motion detection, energy storage devices, and emerging manufacturing platforms, while also addressing opportunities in flexible electronics, interactive technologies, and electronic skin systems. By mapping current performance benchmarks against developmental targets, this work underscores the transformative potential of cellulosic components in eutectogel design and outlines scalable, sustainable pathways for expanding their multifunctional capabilities across diverse technological domains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.